What kind of companies do you help?
We support Nordic life science and health tech companies, typically 20 to 200 employees, that need stronger commercialization, US market entry, or senior commercial leadership without the permanent hire.
An entry-level diagnostic, a scoped sprint into the US, and interim leadership for scale-ups. Everything deeper grows out of one of these three.
Each offer stands on its own and sequences into the next when the moment is right. Start with the diagnostic, run the sprint when the US is the question, keep a senior commercial leader in the room for the year you need one.
A 30 to 45 minute structured session that maps where your organization stands on AI. You leave with an AI Readiness score and 2 to 3 concrete observations. The most common first step, and a natural gateway to the workshop and Total Process Analysis engagements.
A 6 to 8 week scoped engagement. You pick the modules — US market entry, distributor strategy, channel build, partner shortlist, commercial model — and we assemble the sprint around what your commercial function actually needs. Delivered by a partner plus our US-based commercial advisor.
US Market Entry
Market map, prioritized segments, channel decision between direct and distributor, partner shortlist, and the first 10 accounts to approach.
Distributor Strategy
Partner sourcing across EU, US and APAC. Shortlist, onboarding design, incentive structures, and a scaling playbook for cross-border medtech and diagnostics.
Channel Build & Partner Shortlist
Concrete partner targets, intro paths, and the qualifying criteria you need before any first conversation. We cut the long-list down to the few that matter.
Commercial Model & Pricing
Pricing strategy, margin structure, deal economics, and a commercial model your sales and finance teams can operate against.
A 6 to 12 month partnership where we run your commercial function alongside your team — not just deliver documents. Senior commercial leadership, channel and partner management, sales infrastructure, and AI-augmented workflows, until the function is strong enough to hand back.
Our packaged offers sit on top of a deeper capability set. These are the disciplines we draw from — individually or combined, depending on what the work needs.
Market entry planning, segmentation, positioning, value propositions, and channel decisions for Nordic life science companies.
Read morePartnership sourcing, deal structuring, OEM and distributor agreement negotiation, relationship management across US, EU, and APAC.
Read morePartner short-listing, onboarding design, incentive and compensation structures, performance management, and scaling playbooks.
Read moreNordic Investor Scanner (230 VC funds, 3,348 portfolio companies), outbound AI workflows, buying-signal detection, and account mapping.
Read moreTotal Process Analysis maps every commercial and operational process, scores them for friction and revenue impact, and identifies the 3–5 with highest leverage.
Read moreAI running inside your workflow — not in someone else’s cloud. No data leaks, no vendor lock-in. From 29 000 SEK.
Read moreThese are the conversations most teams have before choosing a service track or deciding where to start.
What kind of companies do you help?
We support Nordic life science and health tech companies, typically 20 to 200 employees, that need stronger commercialization, US market entry, or senior commercial leadership without the permanent hire.
Do you work with one specific service or broader commercial programmes?
We have consolidated our work into three productized engagements: an AI Readiness Interview as the entry diagnostic, a Commercialization Sprint with modular scope (US market entry, distributor strategy, channel build, partner shortlist, commercial model), and a Commercialization Retainer for teams that want us running the function alongside them over 6-12 months. Deeper engagements grow out of these.
How do you decide where AI fits in?
We start with business reality rather than tools. The AI Readiness Interview helps identify the few areas where AI can create measurable value before any larger rollout.
Can you support execution as well as strategy?
Yes. The Commercialization Sprint produces an operational plan — the first 10 accounts to approach, partner shortlists, channel decisions, pricing — and Process Mapping & Industrial Implementation installs the AI layer and workflows directly into your team’s daily operations. The work is meant to translate into market traction, not stall as a document.
If you are still clarifying launch strategy or AI priorities, these are the best next pages to read.
A practical guide to the launch decisions and commercial tradeoffs that usually define medical device traction.
A sharper starting point for teams deciding where AI fits before they move into tools or implementation.
One call, 30 minutes. We will tell you which of the three fits, or whether we are the right team at all.